Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine scalp nerve block in meningioma craniotomy
ChiCTR2500110108Phase 4Completed
- Sponsor
- First Affiliated Hospital of Kunming Medical University
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in meningioma (3 arms), sponsored by First Affiliated Hospital of Kunming Medical University. Primary endpoints: Quality of Recovery-15 score (QoR-15), Mini-Mental State Examination score (MMSE) and 1 more. Started Sep 2025; status: completed.
02
Drugs
bupivacaine
03
Conditions
meningioma
Beyond the preview
Go deeper on ChiCTR2500110108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110108.